Beijing Chunlizhengda Medical Instruments Co Ltd - Asset Resilience Ratio
Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has an Asset Resilience Ratio of 25.01% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688236 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Beijing Chunlizhengda Medical Instrument.
Liquid Assets Composition Over Time
This chart breaks down Beijing Chunlizhengda Medical Instruments Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Beijing Chunlizhengda Medical Instrument balance sheet liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥885.47 Million | 25.01% |
| Total Liquid Assets | CN¥885.47 Million | 25.01% |
Asset Resilience Insights
- Very High Liquidity: Beijing Chunlizhengda Medical Instruments Co Ltd maintains exceptional liquid asset reserves at 25.01% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Beijing Chunlizhengda Medical Instruments Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Chunlizhengda Medical Instruments Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Beijing Chunlizhengda Medical Instruments Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 21.52% | CN¥745.80 Million ≈ $109.13 Million |
CN¥3.47 Billion ≈ $507.15 Million |
-1.28pp |
| 2023-12-31 | 22.80% | CN¥832.02 Million ≈ $121.75 Million |
CN¥3.65 Billion ≈ $534.05 Million |
+0.28pp |
| 2022-12-31 | 22.52% | CN¥767.73 Million ≈ $112.34 Million |
CN¥3.41 Billion ≈ $498.96 Million |
-35.37pp |
| 2021-12-31 | 57.89% | CN¥1.74 Billion ≈ $254.10 Million |
CN¥3.00 Billion ≈ $438.94 Million |
+13.08pp |
| 2020-12-31 | 44.81% | CN¥690.12 Million ≈ $100.99 Million |
CN¥1.54 Billion ≈ $225.35 Million |
+12.17pp |
| 2012-12-31 | 32.64% | CN¥61.21 Million ≈ $8.96 Million |
CN¥187.51 Million ≈ $27.44 Million |
-- |
About Beijing Chunlizhengda Medical Instruments Co Ltd
Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, joints, dentures, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or… Read more